Zach Bristow 4.22K Followers Comments Summary Insulet delivers strong fundamentals, with robust revenue growth, high margins, and impressive returns on capital, driven by Omnipod's success. PODD's Q3 results were strong, featuring record revenues, expanding margins, and raised guidance. Despite operational excellence, valuations are extremely demanding, trading at ~15x capital and ~50x forward EBIT, leaving little margin of safety for investors.